Evidence map›Paper›PMID 27501334›Full record

ArticleeLife2016

Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells.

Loïs S Miraucourt, Jennifer Tsui, Delphine Gobert, Jean-François Desjardins, Anne Schohl, Mari Sild, Perry Spratt, Annie Castonguay, Yves De Koninck, Nicholas Marsh-Armstrong and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Assessing circuit function in the developingFrontiers in behavioral neuroscience · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Tonic Endocannabinoid Levels Modulate Retinal Signaling.International journal of environmental research and public health · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. CBNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Loïs S MiraucourtMontreal Neurological Institute, McGill University, Montreal, Canada.ORCID 0000-0003-4812-6342
Jennifer TsuiMontreal Neurological Institute, McGill University, Montreal, Canada.
Delphine GobertMontreal Neurological Institute, McGill University, Montreal, Canada.
Jean-François DesjardinsDepartment of Physics, McGill University, Montreal, Canada.
Anne SchohlMontreal Neurological Institute, McGill University, Montreal, Canada.
Mari SildMontreal Neurological Institute, McGill University, Montreal, Canada.
Perry SprattMontreal Neurological Institute, McGill University, Montreal, Canada.
Annie CastonguayInstitut Universitaire en santé mentale de Québec, Université Laval, Québec, Canada.
Yves De KoninckInstitut Universitaire en santé mentale de Québec, Université Laval, Québec, Canada.
Nicholas Marsh-ArmstrongDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, United States.
Paul W WisemanDepartment of Physics, McGill University, Montreal, Canada.
Edward S RuthazerMontreal Neurological Institute, McGill University, Montreal, Canada.ORCID 0000-0003-0452-3151
Montreal Neurological Institute and Hospital · CAInstitut Universitaire en Santé Mentale de Québec · CAMcGill University · CAKennedy Krieger Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 cannabinoid receptors (CB1Rs) are widely expressed in the vertebrate retina, but the role of endocannabinoids in vision is not fully understood. Here, we identified a novel mechanism underlying a CB1R-mediated increase in retinal ganglion cell (RGC) intrinsic excitability acting through AMPK-dependent inhibition of NKCC1 activity. Clomeleon imaging and patch clamp recordings revealed that inhibition of NKCC1 downstream of CB1R activation reduces intracellular Cl(-) levels in RGCs, hyperpolarizing the resting membrane potential. We confirmed that such hyperpolarization enhances RGC action potential firing in response to subsequent depolarization, consistent with the increased intrinsic excitability of RGCs observed with CB1R activation. Using a dot avoidance assay in freely swimming Xenopus tadpoles, we demonstrate that CB1R activation markedly improves visual contrast sensitivity under low-light conditions. These results highlight a role for endocannabinoids in vision and present a novel mechanism for cannabinoid modulation of neuronal activity through Cl(-) regulation.

Indexed as

AMP-Activated Protein KinasesAnimalsChloridesContrast SensitivityEndocannabinoidsGene Expression RegulationIon TransportLarvaMembrane PotentialsMolecular ImagingPatch-Clamp TechniquesReceptor, Cannabinoid, CB1Recombinant Fusion ProteinsRetinal Ganglion CellsSignal TransductionSolute Carrier Family 12, Member 2AMP-Activated Protein KinasesChloridesclomeleonEndocannabinoidsReceptor, Cannabinoid, CB1Recombinant Fusion ProteinsSolute Carrier Family 12, Member 2CB1 ReceptorchlorideendocannabinoidneuroscienceNKCC1retinavisual systemxenopus

Identifiers

PMID27501334
PMCPMC4987138
OpenAlexW2515945841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.